Aquestive Therapeutics Inc Strategic Asset Allocation Index
Aquestive Therapeutics Inc strategic asset allocation index. Aquestive Therapeutics Inc (AQST) has a Strategic Asset Allocation Index of 121.1% as of December 2018. Strategic assets (PP&E of $12.21 Million plus long-term investments of $-) total $12.21 Million, measured against net assets of $10.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Aquestive Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Aquestive Therapeutics Inc (2005–2018)
Strategic asset allocation index of Aquestive Therapeutics Inc from 2005 to 2018. This chart shows how Aquestive Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2005 to 2018. As of December 2018, the index stands at 121.1%, representing strategic assets of $12.21 Million against net assets of $10.08 Million USD.
Aquestive Therapeutics Inc Strategic Asset Allocation Index by Year (2005–2018)
Aquestive Therapeutics Inc strategic asset allocation index by year from 2005 to 2018. The table below presents the year-by-year Strategic Asset Allocation Index for Aquestive Therapeutics Inc from 2005 to 2018, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Aquestive Therapeutics Inc (AQST) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 121.1% | $12.21 Million | $12.21 Million | $- | $10.08 Million | ▲ +87.2 pp |
| 2006 | 33.9% | $8.56 Million | $8.56 Million | $- | $25.26 Million | ▼ -129.3 pp |
| 2005 | 163.2% | $7.61 Million | $7.61 Million | $- | $4.67 Million | — |